78 related articles for article (PubMed ID: 16402014)
1. An interesting question of Pompe disease. A case report.
Accomando S; Montaperto D; Fragapane ML; Amato GM; Corsello G; Cappello F; Maresi E
Minerva Pediatr; 2005 Dec; 57(6):423-7. PubMed ID: 16402014
[TBL] [Abstract][Full Text] [Related]
2. [Glycogenosis type II, infantile variant. Report of a case and review of the literature].
García Mendoza JJ; Ortega Sánchez A; Acosta Valdez JL; Stanislawski Mielant EC; Navarro Muñoz C; Díaz-Devis C
Arch Inst Cardiol Mex; 1986; 56(4):323-6. PubMed ID: 2945526
[TBL] [Abstract][Full Text] [Related]
3. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
4. Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.
Umapathysivam K; Hopwood JJ; Meikle PJ
Clin Chim Acta; 2005 Nov; 361(1-2):191-8. PubMed ID: 15993875
[TBL] [Abstract][Full Text] [Related]
5. Clinical, pathological, and electron microscopic findings in two Thai children with Pompe disease.
Shotelersuk V; Shuangshoti S; Chotivitayatarakorn P; Chouwsrikul W; Wattanasirmkit V; Maneesri S; Nuayboonma P; Viratchai C; Suwangool P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S271-9. PubMed ID: 12188423
[TBL] [Abstract][Full Text] [Related]
6. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
7. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
8. [Severe form of juvenile type II glycogenosis in a compound-heterozygous boy (Tyr-292--> Cys/Arg-854-->Stop)].
Castro-Gago M; Eirís-Puñal J; Rodríguez-Núñez A; Pintos-Martínez E; Benlloch-Marín T; Barros-Angueira F
Rev Neurol; 1999 Jul 1-15; 29(1):46-9. PubMed ID: 10528311
[TBL] [Abstract][Full Text] [Related]
9. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
[TBL] [Abstract][Full Text] [Related]
10. A case of childhood Pompe disease demonstrating phenotypic variability of p.Asp645Asn.
Kroos MA; Kirschner J; Gellerich FN; Hermans MM; Van Der Ploeg AT; Reuser AJ; Korinthenberg R
Neuromuscul Disord; 2004 Jun; 14(6):371-4. PubMed ID: 15145338
[TBL] [Abstract][Full Text] [Related]
11. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities.
van der Beek NA; Soliman OI; van Capelle CI; Geleijnse ML; Vletter WB; Kroos MA; Reuser AJ; Frohn-Mulder IM; van Doorn PA; van der Ploeg AT
J Neurol Sci; 2008 Dec; 275(1-2):46-50. PubMed ID: 18757064
[TBL] [Abstract][Full Text] [Related]
12. Parental genetic contribution to mode of presentation in Pompe disease.
Cottrill CM; Johnson GL; Noonan JA
Pediatrics; 1987 Mar; 79(3):379-81. PubMed ID: 3469615
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype.
Anneser JM; Pongratz DE; Podskarbi T; Shin YS; Schoser BG
Neurology; 2005 Jan; 64(2):368-70. PubMed ID: 15668445
[TBL] [Abstract][Full Text] [Related]
14. Infantile and late onset form of generalised glycogenosis type II in cattle.
Howell JM; Dorling PR; Cook RD; Robinson WF; Bradley S; Gawthorne JM
J Pathol; 1981 Aug; 134(4):267-77. PubMed ID: 7033492
[TBL] [Abstract][Full Text] [Related]
15. Creatine kinase and lactate dehydrogenase in type 2 glycogenosis (Pompe disease).
Gerson B; Hemphill JM; Rock RC
Arch Pathol Lab Med; 1977 Apr; 101(4):213-5. PubMed ID: 265697
[TBL] [Abstract][Full Text] [Related]
16. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
Katzin LW; Amato AA
J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
[TBL] [Abstract][Full Text] [Related]
17. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
[TBL] [Abstract][Full Text] [Related]
18. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
[TBL] [Abstract][Full Text] [Related]
19. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.
Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A;
Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781
[TBL] [Abstract][Full Text] [Related]
20. A novel missense mutation in the acid alpha-glucosidase gene causing the classic infantile form of Pompe disease.
Dou W; Peng C; Zheng J; Gu X; Fu L; Martiniuk F; Sheng HZ
Clin Chim Acta; 2006 Dec; 374(1-2):145-6. PubMed ID: 16782080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
